A Phase I/II Clinical Trial to Evaluate the Safety, Tolerability, PK/PD Characteristics, and Efficacy of SCTB10

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
Phase Ia to evaluate the safety, tolerability, immunogenicity, and pharmacokinetics of SCTB10 following a single dose in healthy participants
Epistemonikos ID: 956810f7351e28468402729247481a0473427dc5
First added on: Sep 30, 2026